Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001882742 | SCV002231688 | pathogenic | Microcephaly, normal intelligence and immunodeficiency | 2021-07-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with NBN-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Val358Serfs*9) in the NBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBN are known to be pathogenic (PMID: 9590180, 16415040). |
Medical Genetics Laboratory, |
RCV001648487 | SCV001852745 | pathogenic | Ovarian carcinoma | 2021-09-11 | no assertion criteria provided | clinical testing |